Publication details

MErCuRIC1: A phase 1a study of MEK1/2 inhibitor PD-0325901 with cMET inhibitor crizotinib in patients with advanced solid tumours

Authors

WILSON R MIDDLETON MR HOULDEN J VAN Schaeybroeck S ROLFO CD ELEZ E TAIEB J ANDRE T BARDELLI A LAURENT-PUIG P TABERNERO J PEETERS M MAUGHAN T ROBERTS C LOVE S LAWLER M SALTO-TELLEZ M GRAYSON M POPOVICI Vlad DI Nicolantonio F

Year of publication 2016
Type Article in Periodical
Citation
Web http://dx.doi.org/10.1093/annonc/mdw370.28
Doi http://dx.doi.org/10.1093/annonc/mdw370.28